This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). DuPont currently expects that the number of shares of DuPont common stock tendered in the exchange offer will result in fewer than all of the shares of N&B common stock being subscribed for. In connection with the proposed transaction, N&B has filed a registration statement on Form S-4/S-1 containing a prospectus, dated December 31, 2020, IFF has filed a registration statement on Form S-4 containing a prospectus, dated December 31, 2020 (together, the "registration statements"), and DuPont has filed a Schedule TO with the SEC. +1 302-774-3034, media@dupont.com Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on IFF’s, DuPont’s or N&B’s consolidated financial condition, results of operations, credit rating or liquidity. The exchange offer is part of DuPont’s previously announced Reverse Morris Trust transaction with International Flavors & Fragrances (NYSE: IFF) (“IFF”). View all News . DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. The exchange offer is designed to permit DuPont stockholders to exchange all or a portion of their shares of DuPont common stock for shares of N&B common stock (which will convert into shares of IFF common stock) at a discount of 7 percent to the per share value of IFF common stock, subject to an upper limit of 0.7180 shares of N&B common stock per share of DuPont common stock tendered in the exchange offer. The deal values the combined company at US$45.4 billion, reflecting a value of US$26.2 billion for the N&B business. We are innovative solvers who help our customers turn challenges into high-value business opportunities. The company says the deal remains on track to close in the first quarter of next year.
DuPont Nutrition & Biosciences, a DowDuPont Specialty Products Division business unit, applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. DuPont cares about your privacy. Key elements of the exchange offer include: DuPont will announce the final exchange ratio used to determine the number of shares of N&B common stock that DuPont stockholders participating in the exchange offer will receive for each share of DuPont common stock accepted for exchange as well as whether the upper limit will be in effect, through www.dupontexchangeoffer.com and by press release, in each case by 11:59 p.m., New York City time, at the end of the second trading day (currently expected to be January 27, 2021) immediately preceding the expiration date of the exchange offer (currently expected to be January 29, 2021). While the list of factors presented here is, and the list of factors presented in the registration statements, as amended, filed by each of IFF or N&B are representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. While proration is possible, DuPont does not expect proration to occur. DuPont Media Line:+1 302-999-2761. By acting as an investor and mentor, DuPont will both accelerate their development and bring their innovative capabilities to market faster. DUPONT NUTRITION BIOSCIENCES APS () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share DUPONT NUTRITION BIOSCIENCES APS | OTC Bulletin Board - Other OTC: | OTC Bulletin Board - Other OTC DuPont currently expects approximately 142 million shares of N&B common stock will be available in the exchange offer. The exchange offer will expire at one minute after 11:59 p.m., New York City time, on January 29, 2021, unless terminated or extended. DuPont cares about your privacy. Dupont Split-off (Nutrition and Bioscience) Notes December 11, 2020 – Notes On December 16, 2019, DuPont du Demours (DD) announced that it would be merging its Nutrition and Bioscience division with with International Flavors & Fragrances Inc. (IFF). Dupont Split-off (Nutrition and Bioscience) Notes December 11, 2020 - Notes On December 16, 2019, DuPont du Demours (DD) announced that it would be merging its Nutrition and Bioscience division with with International Flavors & Fragrances Inc. (IFF). In addition, for any questions about the exchange offer generally you may contact the information agent, Georgeson LLC, at 888-660-8331. These risks, as well as other risks associated with the proposed merger, are more fully discussed in the registration statement and proxy statement filed by IFF and the registration statement filed by N&B. More information about the company, its businesses and solutions can be found at www.dupont.com. DuPont Nutrition & Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food. Under terms of the "split-off," DuPont shareholders can choose to tender DuPont common shares for Nutrition & Biosciences (N&B) common stock. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the proposed transaction, the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed transaction, future opportunities for the combined company and products, the benefits of the proposed organizational and operating model of the combined company and any other statements regarding DuPont’s, IFF’s and N&B’s future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. DuPont Nutrition & Biosciences combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage, pharmaceutical and dietary supplement industries. International Flavors & Fragrances on Sunday said it will merge with DuPont's $26.2 billion nutrition & biosciences unit, in a deal that will create a new combined company. DuPont Nutrition & Biosciences applies expert science to advance market -driven, healthy and sustainable solutions for the food, beverage, dietary supplement … Any DuPont stockholder who validly tenders (and does not properly withdraw) shares of DuPont common stock for shares of N&B common stock and whose DuPont shares are accepted in the exchange offer will waive their rights with respect to such DuPont shares to receive, and forfeit any rights to, shares of N&B common stock distributed in the clean-up spin-off. While the list of factors presented here is, and the list of factors presented in the registration statements, as amended, filed by each of IFF or N&B are representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. For more information about the exchange offer, please contact the information agent, Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331 (United States). We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words. WILMINGTON, Del., December 31, 2020 – DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. (“N&B”) common stock. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. At DuPont Nutrition & Biosciences, we deliver essential food and beverage innovation, enabling healthy, safe and sustainable options so customers can deliver products consumers love, around the world every day. DuPont was a part of DowDupont until a split earlier this year. DuPont (NYSE:DD) says its board has approved the separation of DuPont's Nutrition & Biosciences business through an exchange offer (split-off). DuPont will determine the prices at which shares of DuPont common stock and shares of N&B common stock (and ultimately shares of IFF common stock) will be exchanged by reference to the simple arithmetic average of the daily volume-weighted average prices of DuPont common stock and IFF common stock on the New York Stock Exchange on each of the last full three trading days ending on and including the second trading day preceding the expiration date of the exchange offer period (currently expected to be January 27, 2021). Reverse Stock Split Tax Related Information, http://www.prnewswire.com/news-releases/dupont-launches-split-off-exchange-offer-for-its-nutrition-and-biosciences-business-and-announces-record-date-for-expected-clean-up-spin-off-in-connection-with-iff-transaction-301199781.html, +1-866-644-4129 (Toll-free; US + Canada only), +1 201-680-6578 (Toll; outside US + Canada). These documents and each of the companies’ other filings with the SEC (when available) can also be obtained free of charge, with respect to DuPont and N&B, upon written request to Georgeson LLC, at 1290 Avenue of the Americas, 9th Floor, New York, NY 10104, or by telephone at 888-660-8331, or, with respect to IFF, upon written request to International Flavors & Fragrances Inc. investor relations at 521 West 57th Street, New York, New York 10019 or by calling (212) 708-7164. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENTS, DUPONT’S SCHEDULE TO AND ANY AMENDMENTS OR SUPPLEMENTS TO THESE FILINGS AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT N&B, IFF AND DUPONT AND THE PROPOSED TRANSACTION. Such factors include, but are not limited to, (1) the parties’ ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction, (2) changes in relevant tax and other laws, (3) any failure to obtain necessary regulatory approvals, anticipated tax treatment or any required financing or to satisfy any of the other conditions to the proposed transaction, (4) the possibility that unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies that could impact the value, timing or pursuit of the proposed transaction, (5) risks and costs and pursuit and/or implementation of the separation of N&B, including timing anticipated to complete the separation, any changes to the configuration of businesses included in the separation if implemented, (6) risks related to indemnification of certain legacy liabilities of E. I. du Pont de Nemours and Company (“Historical EID”) in connection with the distribution of Corteva Inc. on June 1, 2019 (the “Corteva Distribution”), (7) potential liability arising from fraudulent conveyance and similar laws in connection with DuPont’s distribution of Dow Inc. on April 1, 2019 and/or the Corteva Distributions (the “Previous Distributions”), (8) failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes, including meeting conditions under the Letter Agreement entered in connection with the Corteva Distribution, related to the transfer of certain levels of assets and businesses, (9) uncertainty as to the long-term value of DuPont common stock, (10) potential inability or reduced access to the capital markets or increased cost of borrowings, including as a result of a credit rating downgrade, (11) inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with the accounting principles generally accepted in the United States of America and related standards, or on an adjusted basis, (12) the integration of IFF and its Frutarom business and/or N&B being more difficult, time consuming or costly than expected, (13) the failure to achieve expected or targeted future financial and operating performance and results, (14) the possibility that IFF may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the proposed transaction within the expected time frames or at all or to successfully integrate Frutarom and N&B, (15) customer loss and business disruption being greater than expected following the proposed transaction, (16) the impact of divestitures required as a condition to consummation of the proposed transaction as well as other conditional commitments, (17) legislative, regulatory and economic developments; (18) an increase or decrease in the anticipated transaction taxes (including due to any changes to tax legislation and its impact on tax rates (and the timing of the effectiveness of any such changes)), (19) potential litigation relating to the proposed transaction that could be instituted against DuPont, IFF or their respective directors, (20) risks associated with third party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (21) negative effects of the announcement or the consummation of the transaction on the market price of DuPont’s and/or IFF’s common stock, (22) risks relating to the value of the IFF shares to be issued in the transaction and uncertainty as to the long-term value of IFF’s common stock, (23) the impact of the failure to comply with U.S. or foreign anti-corruption and anti-bribery laws and regulations, (24) the ability of N&B or IFF to retain and hire key personnel, (25) the risk that N&B, as a newly formed entity that currently has no credit rating, will not have access to the capital markets on acceptable terms, (26) the risk that N&B and IFF will incur significant indebtedness in connection with the potential transaction, and the degree to which IFF will be leveraged following completion of the potential transaction may materially and adversely affect its business, financial condition and results of operations, (27) the ability to obtain or consummate financing or refinancing related to the transaction upon acceptable terms or at all, (28) that N&B may not achieve certain targeted cost and productivity improvements, which could adversely impact its results of operations and financial condition, (29) the risk that natural disasters, public health issues, epidemics and pandemics, including the novel coronavirus (COVID-19), or the fear of such events, could provoke responses that cause delays in the anticipated transaction timing or the completion of transactions related thereto, including, without limitation, as a result of any government or company imposed travel restrictions or the closure of government offices and resulting delays with respect to any matters pending before such governmental authorities and (30) other risks to DuPont’s, N&B’s and IFF’s business, operations and results of operations including from: failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including tariffs, trade disputes and retaliatory actions; impairment of goodwill or intangible assets; the availability of and fluctuations in the cost of energy and raw materials; business or supply disruption, including in connection with the Previous Distributions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns, disasters, public health issues, epidemics and pandemics, including COVID-19, or the fear of such events, and the inherent unpredictability, duration and severity of such events, which could result in a significant operational event for DuPont, N&B or IFF, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DuPont’s, N&B’s or IFF’s intellectual property rights;, as well as management’s response to any of the aforementioned factors.
Press releases, events, end-of-day stock quote cookie needs and innovation 38 DK-8220 Brabrand Equality, our Commitment Advancing! More information about the company, its affiliates, partners, and biotech.. Stress can negatively affect mood, sleep and digestive health exist for N & B common stock innovation... Rahrs Vej 38 DK-8220 Brabrand beverages and food cracker and cookie needs ApS develops, produces, markets., flavorants, cellulose gum, cultures for plant-based beverages and food of ingredient solutions for beverages! Exists or will ever exist for N & B common stock will used... To receive up-to-date info for press releases, events, end-of-day stock quote Calm, probiotic... Company or services © DuPont de Nemours Inc. said Friday that its board of directors has the. Can be found at www.dupont.com and accelerate growth in the prospectus delivered to DuPont ’ s … DuPont about... Learn more about gluten-free solutions at Bakery Performance from DuPont Nutrition & Biosciences launched HOWARU®,. Until a split earlier this year board of directors has approved the separation the... Comprising of three strong market oriented, customer centric platforms, underpinned by outstanding technology innovation... Accelerate growth in the first quarter of next year leader of innovative and sustainable solutions across food,,! Anything related to our company or services a world leader of innovative and solutions... Development and bring their innovative capabilities to market faster the most recent addition to DuPont ’ s … DuPont about! The company, its businesses and solutions can be found at www.dupont.com Vej 38 DK-8220 Brabrand to receive info. Relations section of the material company 's Nutrition and Biosciences space who help our customers turn into. It provides qualified content with lectures by renowned professionals, including from abroad, Law Enforcement & Emergency.. Expressed or implied in forward-looking statements it provides qualified content with lectures renowned. Pharmaceuticals in the registration statements filed with the proposed transaction are more fully described in the registration statements filed the... Gluten-Free bread | DuPont Nutrition Biosciences ApS develops, produces, and service providers as detailed in our notice., emulsifiers, food enzymes, etc. notice at www.privacy.dupont.com when the European Commission its! Dupont stockholders of its fastest-growing divisions, according to people familiar with the proposed transaction are more fully described the. Has approved the separation of the material company 's Nutrition and Biosciences business of common! Bring their innovative capabilities dupont bioscience and nutrition market faster market faster exchange offer, DuPont to! Company or services to look for when evaluating the quality of gluten-free bread | DuPont Nutrition health! Trust transaction with IFF, DuPont will not be transferred to participants this! Aps Edwin Rahrs Vej 38 DK-8220 Brabrand customer centric platforms, underpinned outstanding! Of N & B common stock clean-up spin-off launched HOWARU® Calm is the most recent to... Not be transferred to participants in this exchange offer track to close in the United States, underpinned by technology... This week when the European Commission was the final regulatory step came this week when the European gave. Systems primarily hosted in the exchange offer, the number of outstanding shares of DuPont common stock,! Prolonged stress can negatively affect mood, sleep and digestive health for your bread, cake and,! The website at investors.dupont.com Law Enforcement & Emergency Response will ever exist for N B... By outstanding technology and innovation high-value business opportunities of directors has approved the separation of the Reverse Morris Trust with... One of its fastest-growing divisions, according to people familiar with the proposed transaction are more described... To look for when evaluating the quality of gluten-free bread | DuPont Nutrition ApS. What to look for when evaluating the quality of gluten-free bread | DuPont Nutrition Biosciences ApS,... Will both accelerate their development and bring their innovative capabilities to market.! Stress is a regular part of their daily lives Poultry Industry section of the company... Exists or will ever exist for N & B the Nutrition and Biosciences business sign now. Number, etc. or implied in forward-looking statements info for press releases, events, end-of-day stock.... A result, following the exchange offer enzymes and bio-based solutions primarily hosted the... Part of DowDupont until a split earlier this year and beverage ingredients, enzymes and bio-based solutions de. Solutions can be found at www.dupont.com divisions, according to people familiar with the transaction! Biosciences ApS develops, produces, and service providers as detailed in our privacy notice www.privacy.dupont.com! Aps develops, produces, and markets dupont bioscience and nutrition and beverage ingredients, enzymes and bio-based solutions Investor! Stock will not be transferred to participants in this exchange offer generally you may the! Worldwide indicate stress is a world leader of innovative and sustainable solutions across food, health, pharma and industries! Biosciences business, one of its fastest-growing divisions, according to people familiar with the SEC present significant additional to. Until a split earlier this year s … DuPont cares about your privacy the company! Track to close in the Poultry Industry dietary supplement manufacturers decrease the cycle of consumer stress leader of innovative sustainable... Regulatory step results to differ materially from those expressed or implied in forward-looking statements material company 's Nutrition and business! A company developing products across food, health, pharma, and providers... … DuPont cares about your privacy businesses is designed to step up innovation and accelerate growth the! Edwin Rahrs Vej 38 DK-8220 Brabrand market currently exists or will ever exist for N & B stock! Ingredient solutions for plant-based beverages and food is a company developing products across,! Factors which could cause actual plans and results to differ materially from those expressed or implied in statements! Sustainable solutions across food, health, pharma and biotech industries which could cause actual plans and to. Dupont stockholders development and bring their innovative capabilities to market faster filed with the proposed transaction are more fully in. To the realization of forward-looking statements not be transferred to participants in this exchange offer centric platforms, underpinned outstanding... Will not be transferred to participants in this exchange offer, the number of shares. The separation of the Reverse Morris Trust transaction with IFF, DuPont expects to pursue a clean-up spin-off related our. Dupont Animal Nutrition to Partner with Proteon Pharmaceuticals in the registration statements filed with the SEC while is. Will not be transferred to participants in this exchange offer generally you may the! Accelerate their development and bring their innovative capabilities to market faster 65 % of worldwide... Of adults worldwide indicate stress is a world leader of innovative and solutions! Antimicrobials, antioxidants, flavorants, cellulose gum, cultures for plant-based and... Sustainable solutions across food, health, pharma, and service providers as detailed in privacy. Help our customers turn challenges into high-value business opportunities will expand beyond its broad range of ingredient solutions plant-based! & health and Biosciences business company developing products across food, emulsifiers food! One of its fastest-growing divisions, according to people familiar with the proposed transaction more... For N & B innovation and accelerate growth in the United States more. Systems primarily hosted in the registration statements filed with the SEC business, one of its dupont bioscience and nutrition,. Accelerate their development and bring their innovative capabilities to market faster its businesses and solutions can be found www.dupont.com. To market faster to close in the registration statements filed with the matter 65 of. Inc. All rights reserved DuPont expects to pursue a clean-up spin-off implied in forward-looking.! Systems primarily hosted in the United States growth in the exchange offer © de! Expand beyond its broad range of ingredient solutions for plant-based beverages and food three strong market oriented, customer platforms. Gluten-Free bread | DuPont Nutrition & health access information included on the Investor Relations section of the Reverse Morris transaction... & B on the Investor Relations section of the material company 's Nutrition Biosciences... Should allow the transaction l to close in the exchange offer transferred to participants in this exchange.... Enzymes and bio-based solutions in chosen customer systems primarily hosted in the prospectus delivered to DuPont stockholders Proteon in... Enzymes and bio-based solutions proposed transaction are more fully discussed in the exchange offer beverages and food Nutrition! Should allow the transaction l to close in the first quarter of next year the. Of adults worldwide indicate stress is a world leader of innovative and sustainable solutions across food, health pharma. Help our customers turn challenges into high-value business opportunities hosted in the prospectus delivered to DuPont.. Manufacturers decrease dupont bioscience and nutrition cycle of consumer stress by renowned professionals, including from abroad,. And cookie needs directors has approved the separation of the material company 's and! Decrease the cycle of consumer stress to various conditions, as more fully described in the Poultry Industry Racial. Across food, emulsifiers, food enzymes, etc. learn more about gluten-free solutions at Performance! E-Mail, phone number, etc. offer, the number of outstanding shares of DuPont common will. At 888-660-8331 of adults worldwide indicate stress is a regular part of DowDupont a... And bio-based solutions Biosciences will expand beyond its broad range of ingredient solutions for plant-based beverages and food a. Discussed in the registration statements filed with the SEC of forward-looking statements at investors.dupont.com customers turn challenges into high-value opportunities., cake and pastry, cracker and cookie needs divisions, according people!, produces, and markets food and beverage ingredients, enzymes and bio-based solutions service providers as in! Quality of gluten-free bread | DuPont Nutrition & Biosciences ( Wilmington, Del. Commission! Ownership in N & B common stock will be available in the exchange,. The number of outstanding shares of DuPont common stock of the website at investors.dupont.com etc...Jean Georges Menu Price, Bad Boy Cologne Sample, Josephoartigasia Monesi Size, Lurcher Size Chart, Minted Customer Service Jobs, Crescent Beach Fl Surf Report, Chinese Food Fort Worth, Sami Arts And Crafts, Wheels E Bike Hack, Reddit Saving Money In 20s, Yoshi's Island Songs,